U.S. Biotech Stock News

Teleflex Incorporated recently announced that its Barrigel rectal spacer is now available for purchase in Japan after securing regulatory approval, insurance coverage, and academic endorsement, with the first commercial cases commencing earlier this month. This marks the debut of the first and only sculptable non-animal stabilized hyaluronic acid rectal spacer in Japan, widening patient access to advanced prostate radiation therapy solutions in a major international healthcare market. We'll...

On August 8, 2025, Alpha Metallurgical Resources announced its second quarter and first half earnings, reporting revenue of US$550.27 million and a net loss of US$4.95 million for the quarter, both down substantially from the previous year, while also confirming that no shares were repurchased during this period. This shift from net profit to net loss amid declining sales marked a significant departure from the company’s recent financial trends and may raise investor concerns about near-term...

Earlier in August 2025, NuScale Power Corporation filed a US$500 million at-the-market equity offering and a US$177.1 million shelf registration, covering a range of securities including common and preferred stock, depositary shares, debt securities, warrants, and units. These capital-raising actions suggest efforts to reinforce financial flexibility but also raise the possibility of share dilution, which often prompts investor reassessment of long-term growth and funding needs. We'll look...

Welltower (WELL) has recently caught the attention of investors after its stock added nearly 1.5% in a single day, continuing a run of steady gains over the past month. While there was not a single headline-grabbing event driving the uptick, the consistent climb may prompt shareholders and potential buyers to consider whether the market is reassessing the company’s growth prospects. With strong financial results reported in the last quarter and growing investor appetite for real estate...

Thinking of buying, holding, or selling Altria Group stock? You are definitely not alone. With this long-standing tobacco giant trading at $67.58 recently, investors are watching its moves closely and crunching the numbers to decide their next step. Over the past month, Altria’s stock price has jumped almost 15%, while its year-to-date return is up an impressive 28.7%. Those strong returns, especially the 40% gain over the past year, have stirred up plenty of talk about the company’s growth...

Hertz Car Sales recently announced a nationwide expansion of its Rent2Buy® program and a collaboration with Amazon, allowing customers to browse, finance, and purchase pre-owned vehicles directly through Amazon Autos in over 100 cities. This move highlights a shift in the used car market as traditional rental firms embrace digital retail models, creating new competition for established online auto retailers. We'll explore how Hertz's partnership with Amazon to sell used vehicles online could...

If you are wrestling with what to do about Warner Bros. Discovery stock right now, you are not alone. After a rocky few years, WBD has staged a notable comeback, with shares up over 50% in the last year. Despite a dip of nearly 10% in the past month and a recent price target cut from Raymond James, analysts still seem optimistic about longer-term potential. This sentiment comes as the company navigates challenging industry shifts, such as recent layoffs and evolving content strategies. Some...

On August 7, 2025, the Board of Directors of NewMarket Corporation declared a quarterly dividend of US$2.75 per share, payable October 1, 2025, to shareholders of record as of September 15, 2025. Unique among its peers, NewMarket's strong return on equity, currently around 30%, has been matched by above-average net income growth and robust earnings reinvestment strategies. We’ll now explore how NewMarket’s ongoing reinvestment of profits shapes its investment narrative in light of its...

iRhythm Technologies announced that a large real-world study published in the American Journal of Managed Care found its Zio® long-term continuous monitoring (LTCM) service outperformed other ambulatory cardiac monitoring methods in clinical outcomes, diagnostic speed, and healthcare cost reduction for commercially insured adults in the U.S. This publication expands on prior findings in Medicare patients and highlights the value of Zio LTCM with the highest rate of new arrhythmia diagnoses,...

Thinking about what to do with Uber Technologies stock? You are not alone. With the share price recently closing at $93.73, Uber continues to catch investors’ attention in a big way. The watercooler conversations have only picked up as the stock has delivered a 48% gain year-to-date and climbed over 2,200% in the last three years. While there was a slight slip of about 1.7% yesterday, it has mostly been a story of steady gains and improving sentiment over the past few months. What is driving...

White Mountains Insurance Group previously reported its second quarter 2025 results, with revenue rising to US$689.2 million and net income turning to US$122.9 million from a net loss a year before. This reflects a strong reversal in performance for the quarter, as basic and diluted earnings per share moved into positive territory from prior-year losses. We will explore how the company’s shift from a quarterly net loss to net profit shapes its investment narrative moving forward. AI is about...

If you have ever debated whether now is the right moment to buy, sell, or simply hold onto Snap stock, you are definitely not alone. The past year has been a wild ride for Snap’s share price. After peaking hopes, the stock has dropped about 24% over the past 12 months and is down more than 66% across five years. Most recently, shares closed at $7.16, off nearly 28% in just the past month. Investors are searching for answers, especially as swings in social media stocks keep hitting the...

On August 12, 2025, Liquidia Corporation reported its second quarter and six-month financial results, revealing revenue growth to US$8.84 million and US$11.96 million respectively, but wider net losses of US$41.58 million for the quarter and US$79.95 million for the half-year. This report highlighted a significant surge in revenue year-over-year, even as net losses and per-share losses increased compared to the previous periods. We'll examine how Liquidia's increased revenue amid a larger...

Affirm Holdings (AFRM) has just delivered a move that is likely to spark debate among investors wondering what comes next. The stock saw a sudden shift, dipping about 1% in the most recent session. This comes after a month marked by significant swings, including a jump of more than 9%. There is no headline event or breaking development driving today’s price action. Sometimes these quieter stretches are where signals hide in plain sight, raising the real question of whether the market is...

If you’ve been tracking Vistra lately, you know it’s been anything but boring. Maybe you’re wondering if now is the time to buy, sell, or sit tight on your shares, or if you’re missing out on a rising star. Over the past year, Vistra’s stock has surged by more than 136%, delivering eye-popping gains compared to the broader utility sector. The climb isn’t just a short-term story either, with the 3-year and 5-year returns at roughly 710% and over 1,050%, respectively. That kind of performance...

United Fire Group, Inc. ( NASDAQ:UFCS ) will pay a dividend of $0.16 on the 12th of September. Based on this payment...

In the past quarter, Incyte delivered exceptional results with revenues exceeding analysts’ estimates by 9.1%, fueled by robust growth in Jakafi®, Opzelura®, and Niktimvo™. This performance highlights not only Incyte’s strong momentum in the immuno-oncology space, but also broader sector strength as peers like Regeneron, Natera, and Exact Sciences similarly surpassed expectations. We’ll now explore how Incyte’s Q2 revenue outperformance and product growth could influence its long-term...

Thinking about what to do with GlobalFoundries stock? You are not alone. GFS has kept investors on their toes lately, thanks to a string of notable price movements and a valuation that is catching savvy eyes. Over the past year, shares have tumbled nearly 28%, and the year-to-date drop stands at 22%. Even over the past ninety days, GFS is down nearly 12%. This pattern of declines has shifted perceptions around GlobalFoundries, with current sentiment landing somewhere between cautious...

If you follow Rivian Automotive (RIVN), the recent dip in the company’s stock price may have caught your eye. Shares have slid over 11% in the past month, continuing a downward trend that has sparked questions about how the market is weighing Rivian’s growth prospects against new risks. While no single headline caused the move, the decline is attracting investors who are re-examining what is currently being priced in for this electric vehicle maker. This latest slide follows a year marked by...

When a major leadership change hits a financial institution, investors naturally tune in. Citizens Financial Group (CFG) just announced that Aunoy Banerjee, currently CFO at Barclays Bank PLC, will take over as its new Chief Financial Officer this fall. Banerjee brings deep experience from major players like Barclays, State Street, and Citi. He will step in after outgoing CFO John Woods departs, with interim CFO Chris Emerson serving in the role until Banerjee’s arrival. For a bank of...

Trying to decide what to do with Bristol-Myers Squibb stock? You are not alone. The big pharma name, with its deep pipeline and decades-long track record, has had a rocky road lately, but there are hints that the story could be changing. Over the past month, shares have climbed over 3%, and it looks like investors are starting to price in both new risks and fresh opportunities around the company. Much of this movement has followed ongoing talk out of Washington about pharmaceutical tariffs...

GE HealthCare Technologies (GEHC) has recently drawn attention as its stock edged lower following a quiet stretch for headline news. While no single event sparked the move, some investors are now taking a closer look, wondering if the shift is an early signal for deeper value or simply a reflection of shifting sentiment in the broader healthcare sector. With the conversation around healthcare innovation heating up lately, this subtle change might be enough to nudge GE HealthCare Technologies...

If you are weighing whether to buy, hold, or sell Western Digital stock right now, you are not alone. This storied data storage giant has been on a bit of a rollercoaster lately, capturing the attention of both risk-tolerant growth seekers and valuation-minded investors. Over the last three months, Western Digital shares have surged over 51%, and the stock price is up an impressive 54% over the past year. If you zoom out to three or five years, returns have more than doubled and nearly...

Post Holdings reported third-quarter earnings with sales of US$1.98 billion and net income of US$108.8 million, both showing increases from the same period last year; the company also completed a significant tranche of its share repurchase program and announced upcoming leadership changes, with Nicolas Catoggio named as the next Chief Operating Officer. The simultaneous announcement of leadership succession and a completed share buyback signals both operational continuity and management’s...